T 1602/10 (Anti-TIM-3 antibodies for the treatment of cancer/BRIGHAM) of 17.03.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T160210.20150317
- Date of decision
- 17 March 2015
- Case number
- T 1602/10
- Petition for review of
- -
- Application number
- 03723627.0
- IPC class
- C07K 16/28A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions and methods related to TIM-3, a Th1-specific cell surface molecule
- Applicant name
- The Brigham and Women's Hospital, Inc.
Dana-Farber Cancer Institute, Inc. - Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Sufficiency of disclosure - (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.